India, Oct. 9 -- In wake of health risks posed by faulty cough syrups, the district's health department on Wednesday issued an advisory for safe use of the drug in children below the age of five years.

Officials said that excessive levels of diethylene glycol, a toxic substance, were found in Coldrif cough syrup manufactured in Tamil Nadu.

"We have instructed seizure of the remaining stock of Coldrif from all retail stores, distributors, and health centres," said Dr Alka Singh, chief medical officer (CMO) of Gurugram.

Earlier, officials from Haryana's Food and Drug Administration conducted a surprise inspection on Monday, and 31 samples from multiple private-run pharmacies and wholesalers were collected after the death of at least 12 c...